Form 4: Insider Boosts STAA Stake with Multi-Day Purchases

Broadwood Partners and affiliated insiders significantly increased their beneficial ownership in STAAR Surgical Co. through open market purchases.

Summary

• Broadwood Partners, L.P., a 10% owner and entity associated with a director, acquired additional common stock in STAAR Surgical Co. (STAA) over three days in March 2026.
• On March 11, 2026, 54,764 shares were purchased at a weighted average price of $17.5217 per share.
• On March 12, 2026, 299,432 shares were purchased at a weighted average price of $18.1154 per share.
• On March 13, 2026, 316,017 shares were purchased at a weighted average price of $18.615 per share.
• Following these transactions, Broadwood Partners, L.P. directly holds 16,123,842 shares of common stock.
• Broadwood Capital, Inc. and Neal C. Bradsher are deemed indirect beneficial owners of these shares, with Neal C. Bradsher also directly owning 25,900 shares.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, as substantial insider buying by a major shareholder and director often indicates high confidence in the company's prospects and potential for future appreciation.

Positives

• Significant insider buying by a 10% owner and director-affiliated entities suggests confidence in the company's future prospects.
• The purchases occurred over multiple days, indicating a sustained buying interest.
• The total acquired shares represent a substantial increase in their beneficial ownership.

Future Outlook

This filing does not contain any explicit forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that significant insider purchases, especially by a large institutional investor and director, often signal a belief in the company's undervaluation or strong future growth potential within its sector, which for STAAR Surgical is the ophthalmic medical device industry.

Related Party Transactions

• The reported acquisitions of common stock by Broadwood Partners, L.P., Broadwood Capital, Inc., and Neal C. Bradsher are related party transactions, as these entities and individuals are 10% owners and/or directors of STAAR Surgical Co.

Stakeholder Impact

• Shareholders: Existing shareholders may view this insider buying as a positive indicator, potentially increasing confidence and demand for the stock.

Key Dates

Recommendation

The significant and sustained insider buying by a major institutional investor and director, Broadwood Partners and its affiliates, signals strong conviction in STAAR Surgical Co.'s future value. Such actions by well-informed insiders often precede positive stock performance, making it a compelling 'buy' signal for seasoned investors.

Keywords

STAAR Surgical, STAA, Insider Buying, Form 4, Broadwood Partners, Broadwood Capital, Neal C. Bradsher, Equity Acquisition, 10% Owner, Director Transaction